At the recent OMTEC 2012 Conference in Chicago, there was a panel discussion on the current status and future challenges facing the orthapaedic industry.  Interestingly enough, it seems similar adversities stretch across most of the clinical research industry touching various segments.

The road to market approval for orthopaedic devices can be long and arduous, but it is impossible without valid data. Regulations governing practices in clinical research demand the highest level of ethical and clinical standards, with patient protection as the highest priority.